Citations (176)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Diego Pilati & Kenneth A. Howard. (2020) Albumin-based drug designs for pharmacokinetic modulation. Expert Opinion on Drug Metabolism & Toxicology 16:9, pages 783-795.
Read now
Read now
Biyan Wen, Lin Zhao, Yuchu Wang, Chuangnan Qiu, Zhimin Xu, Kunling Huang, He Zhu, Zemin Li & Huangjin Li. (2020) Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1). Preparative Biochemistry & Biotechnology 50:3, pages 252-259.
Read now
Read now
Azadeh Reshadmanesh, Fatemeh Rahbarizadeh, Davoud Ahmadvand & Farnoush Jafari Iri Sofla. (2018) Evaluation of cellular and transcriptional targeting of breast cancer stem cells via anti-HER2 nanobody conjugated PAMAM dendrimers. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 105-115.
Read now
Read now
Alessandro Allegra, Vanessa Innao, Demetrio Gerace, Doriana Vaddinelli, Andrea Gaetano Allegra & Caterina Musolino. (2018) Nanobodies and Cancer: Current Status and New Perspectives. Cancer Investigation 36:4, pages 221-237.
Read now
Read now
Yuan Yu, Jialu Li, Xuejun Zhu, Xiaowen Tang, Yangyi Bao, Xiang Sun, Yuhui Huang, Fang Tian, Xiaomei Liu & Lin Yang. (2017) Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential. International Journal of Nanomedicine 12, pages 1969-1983.
Read now
Read now
Rebecca Christine Feiner & Kristian Mark Müller. (2016) Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. Expert Review of Proteomics 13:9, pages 817-832.
Read now
Read now
Sander A. A. Kooijmans, Clara Gómez Aleza, Steve R. Roffler, Wouter W. van Solinge, Pieter Vader & Raymond M. Schiffelers. (2016) Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. Journal of Extracellular Vesicles 5:1.
Read now
Read now
Sara Minaeian, Fatemeh Rahbarizadeh, Sayyed
Hamid Zarkesh Esfahani & Davoud Ahmadvand. (2012) CHARACTERIZATION AND ENZYME-CONJUGATION OF A SPECIFIC ANTI-L1 NANOBODY. Journal of Immunoassay and Immunochemistry 33:4, pages 422-434.
Read now
Read now
Chen Chen, Antony Constantinou & Mahendra Deonarain. (2011) Modulating antibody pharmacokinetics using hydrophilic polymers. Expert Opinion on Drug Delivery 8:9, pages 1221-1236.
Read now
Read now
Fatemeh Rahbarizadeh, Davoud Ahmadvand & Zahra Sharifzadeh. (2011) Nanobody; an Old Concept and New Vehicle for Immunotargeting. Immunological Investigations 40:3, pages 299-338.
Read now
Read now
Nicholas C Nicolaides, Philip M Sass & Luigi Grasso. (2010) Advances in targeted therapeutic agents. Expert Opinion on Drug Discovery 5:11, pages 1123-1140.
Read now
Read now
Alain Beck, Janice M. Reichert & Thierry Wurch. (2010) 5th European Antibody Congress 2009. mAbs 2:2, pages 108-128.
Read now
Read now
Itai Benhar. (2007) Design of synthetic antibody libraries. Expert Opinion on Biological Therapy 7:5, pages 763-779.
Read now
Read now
Paul M Watt, Tatjana K Heinrich & Wayne R Thomas. (2006) Protein silencing with Phylomers: a new tool for target validation and generating lead biologicals targeting protein interactions. Expert Opinion on Drug Discovery 1:5, pages 491-502.
Read now
Read now
Articles from other publishers (162)
Racha Kassem, Anne Cousin, Daniel Clesse, Vianney Poignavent, Adrien Trolet, Christophe Ritzenthaler, Thierry Michon, Arnaud Chovin & Christophe Demaille. (2024) Nanobody-guided redox and enzymatic functionalization of icosahedral virus particles for enhanced bioelectrocatalysis. Bioelectrochemistry 155, pages 108570.
Crossref
Crossref
Ashley Suris, Yubin Zhou & Yun Huang. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
96
111
.
Xin Gao, Joseph W. Thrush, Jayesh Gor, James H. Naismith, Raymond J. Owens & Stephen J. Perkins. (2023) The solution structure of the heavy chain–only C5-Fc nanobody reveals exposed variable regions that are optimal for COVID-19 antigen interactions. Journal of Biological Chemistry 299:11, pages 105337.
Crossref
Crossref
Siyu Zhou, Xiaofeng Fang, Jiahui Lv, Yicheng Yang, Yiqi Zeng, Ying Liu, Weijun Wei, Gang Huang, Bo Zhang & Changfeng Wu. (2023) Site-Specific Modification of Single Domain Antibodies by Enzyme-Immobilized Magnetic Beads. Bioconjugate Chemistry 34:10, pages 1914-1922.
Crossref
Crossref
Sara Colja, Ivana Jovčevska, Neja Šamec, Rok Romih & Alja Zottel. (2023) Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles. Heliyon 9:5, pages e15674.
Crossref
Crossref
Ajay Kumar Shukla & Saurav Misra. (2023) Bispecific antibodies and its applications: a novel approach for targeting SARS-Cov-2. Journal of Basic and Clinical Physiology and Pharmacology 34:2, pages 161-168.
Crossref
Crossref
Frederick R. Cross, Peter C. Fridy, Natalia E. Ketaren, Fred D. Mast, Song Li, J. Paul Olivier, Kresti Pecani, Brian T. Chait, John D. Aitchison & Michael P. Rout. (2023) Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2. Journal of Biological Chemistry 299:3, pages 102954.
Crossref
Crossref
Qiang Zeng, Zhigang Liu, Ting Niu, Chuan He, Ying Qu & Zhiyong Qian. (2023) Application of nanotechnology in CAR-T-cell immunotherapy. Chinese Chemical Letters 34:3, pages 107747.
Crossref
Crossref
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik & Ivana Jovčevska. (2023) Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo. Cancers 15:3, pages 573.
Crossref
Crossref
Ahmed Alsadig, Behnaz Abbasgholi-NA, Hendrik Vondracek, Barbara Medagli, Sara Fortuna, Paola Posocco, Pietro Parisse, Humberto Cabrera & Loredana Casalis. (2022) DNA-Directed Protein Anchoring on Oligo/Alkanethiol-Coated Gold Nanoparticles: A Versatile Platform for Biosensing Applications. Nanomaterials 13:1, pages 78.
Crossref
Crossref
Manoj Bansode, Kaushik Deb & Sarmistha Deb. 2022. Targeted Drug Delivery. Targeted Drug Delivery
327
347
.
Luigi Liguori, Giovanna Polcaro, Annunziata Nigro, Valeria Conti, Carmine Sellitto, Francesco Perri, Alessandro Ottaiano, Marco Cascella, Pio Zeppa, Alessandro Caputo, Stefano Pepe & Francesco Sabbatino. (2022) Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics 14:11, pages 2442.
Crossref
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24.
Crossref
Crossref
Monica L. Fernández-Quintero, Eugene F. DeRose, Scott A. Gabel, Geoffrey A. Mueller & Klaus R. Liedl. (2022) Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR. International Journal of Molecular Sciences 23:10, pages 5419.
Crossref
Crossref
Yue Wang, Yaxian Mei, Zhenghong Ao, Yuanzhi Chen, Yichao Jiang, Xiaoqing Chen, Ruoyao Qi, Baorong Fu, Jixian Tang, Mujin Fang, Min You, Tianying Zhang, Quan Yuan, Wenxin Luo & Ningshao Xia. (2022) A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy. Antiviral Research 199, pages 105265.
Crossref
Crossref
Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen & Liqiang Pan. (2022) Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Song Liu, Guanghui Li, Lei Ding, Jin Ding, Qian Zhang, Dan Li, Xingguo Hou, Xiangxing Kong, Jing Zou, Shiming Zhang, Hongbin Han, Yakun Wan, Zhi Yang & Hua Zhu. (2022) Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice. Research 2022.
Crossref
Crossref
Mohammadreza Nassiri, Reihane Behnam-Rasouli, Masoume Vakili-Azghandi, Vinod Gopalan, Peyman Dolati & Rouhollah Nourmohammadi. (2022) Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy. Life Sciences 289, pages 120222.
Crossref
Crossref
Dhritiman Chakraborty, Abhijit Das & C. S. Bal. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology
217
236
.
Jan Gettemans. 2022. Single-Domain Antibodies. Single-Domain Antibodies
373
393
.
Parnaz Merikhian, Behrad Darvishi, Neda Jalili, Mohammad Reza Esmailinejad, Azadeh Sharif Khatibi, Shima Moradi Kalbolandi, Malihe Salehi, Marjan Mosayebzadeh, Mahdieh Shokrollahi Barough, Keivan Majidzadeh‐A, Fatemeh Yadegari, Fatemeh Rahbarizadeh & Leila Farahmand. (2021) Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors. Molecular Oncology 16:2, pages 485-507.
Crossref
Crossref
Fred D Mast, Peter C Fridy, Natalia E Ketaren, Junjie Wang, Erica Y Jacobs, Jean Paul Olivier, Tanmoy Sanyal, Kelly R Molloy, Fabian Schmidt, Magdalena Rutkowska, Yiska Weisblum, Lucille M Rich, Elizabeth R Vanderwall, Nicholas Dambrauskas, Vladimir Vigdorovich, Sarah Keegan, Jacob B Jiler, Milana E Stein, Paul Dominic B Olinares, Louis Herlands, Theodora Hatziioannou, D Noah Sather, Jason S Debley, David Fenyö, Andrej Sali, Paul D Bieniasz, John D Aitchison, Brian T Chait & Michael P Rout. (2021) Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. eLife 10.
Crossref
Crossref
Lu Zhang, Lizhen Wang, Shuaishuai Cao, Huanhuan Lv, Jingjing Huang, Guixi Zhang, Kaissar Tabynov, Qin Zhao & En-Min Zhou. (2021) Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages. Veterinary Research 52:1.
Crossref
Crossref
Guangfa Bao, Ming Tang, Jun Zhao & Xiaohua Zhu. (2021) Nanobody: a promising toolkit for molecular imaging and disease therapy. EJNMMI Research 11:1.
Crossref
Crossref
Lu Han, Ji-Shuai Zhang, Jian Zhou, Ke-Shu Zhou, Ben-Ling Xu, Lin-Lin Li, Bai-Jun Fang, Qing-Song Yin, Xing-Hu Zhu, Hu Zhou, Xu-Dong Wei, Hong-Chang Su, Bing-Xiang Zhang, Ya-Nan Wang, Bin Xiang, Quan-Li Gao & Yong-Ping Song. (2021) Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma. Leukemia 35:10, pages 3002-3006.
Crossref
Crossref
Zahra Asefy, Sirus Hoseinnejhad & Zaker Ceferov. (2021) Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment. Neurological Sciences 42:7, pages 2653-2660.
Crossref
Crossref
Manman Liu, Li Li, Duo Jin & Yangzhong Liu. (2021) Nanobody—A versatile tool for cancer diagnosis and therapeutics. WIREs Nanomedicine and Nanobiotechnology 13:4.
Crossref
Crossref
Betül Altunay, Agnieszka Morgenroth, Mohsen Beheshti, Andreas Vogg, Nicholas C. L. Wong, Hong Hoi Ting, Hans-Jürgen Biersack, Elmar Stickeler & Felix M. Mottaghy. (2020) HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. European Journal of Nuclear Medicine and Molecular Imaging 48:5, pages 1371-1389.
Crossref
Crossref
Holly L. Birchenough, Hilda D. Ruiz Nivia & Thomas A. Jowitt. (2021) Interaction standards for biophysics: anti-lysozyme nanobodies. European Biophysics Journal 50:3-4, pages 333-343.
Crossref
Crossref
Xuan Zheng, Dirk M. Hermann, Mathias Bähr & Thorsten R. Doeppner. (2021) The role of small extracellular vesicles in cerebral and myocardial ischemia—Molecular signals, treatment targets, and future clinical translation. Stem Cells 39:4, pages 403-413.
Crossref
Crossref
Thomanai Lamtha, Lueacha Tabtimmai, Kunan Bangphoomi, Duangnapa Kiriwan, Aijaz A Malik, Wanpen Chaicumpa, Paul M P van Bergen en Henegouwen & Kiattawee Choowongkomon. (2021) Generation of a nanobody against HER2 tyrosine kinase using phage display library screening for HER2-positive breast cancer therapy development. Protein Engineering, Design and Selection 34.
Crossref
Crossref
Markus Kilisch, Hansjörg Götzke, Maja Gere-Becker, Alexander Crauel, Felipe Opazo & Steffen Frey. (2021) Discovery and Characterization of an ALFA-Tag-Specific Affinity Resin Optimized for Protein Purification at Low Temperatures in Physiological Buffer. Biomolecules 11:2, pages 269.
Crossref
Crossref
Seyed Samad Hosseini, Saeed Khalili, Behzad Baradaran, Negar Bidar, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Ahad Mokhtarzadeh & Michael R. Hamblin. (2021) Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials. International Journal of Biological Macromolecules 167, pages 1030-1047.
Crossref
Crossref
Tim Hebbrecht, Jing Liu, Olivier Zwaenepoel, Gaëlle Boddin, Chloé Van Leene, Klaas Decoene, Annemieke Madder, Kevin Braeckmans & Jan Gettemans. (2020) Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging. New Biotechnology 59, pages 33-43.
Crossref
Crossref
Manman Liu, Yang Zhu, Tiantian Wu, Junjie Cheng & Yangzhong Liu. (2020) Nanobody‐Ferritin Conjugate for Targeted Photodynamic Therapy. Chemistry – A European Journal 26:33, pages 7442-7450.
Crossref
Crossref
Yushu Joy Xie, Michael Dougan, Jessica R. Ingram, Novalia Pishesha, Tao Fang, Noor Momin & Hidde L. Ploegh. (2020) Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments. Cancer Immunology Research 8:4, pages 518-529.
Crossref
Crossref
Manzoor A. Mir, Umar Mehraj, Bashir Ahmad Sheikh & Syed Suhail Hamdani. (2020) Nanobodies: The “Magic Bullets” in therapeutics, drug delivery and diagnostics. Human Antibodies 28:1, pages 29-51.
Crossref
Crossref
Amir S. Razai, Brendan P. Eckelman & Guy S. Salvesen. (2020) Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody. Journal of Biological Chemistry 295:8, pages 2464-2472.
Crossref
Crossref
Alja Zottel, Ivana Jovčevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar & Radovan Komel. (2020) Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration. Therapeutic Advances in Medical Oncology 12, pages 175883592091530.
Crossref
Crossref
Stephen J. Bagley & Donald M. O’Rourke. (2020) Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacology & Therapeutics 205, pages 107419.
Crossref
Crossref
Matheus Vitor Ferreira Ferraz, Wenny Camilla dos Santos Adan & Roberto Dias Lins. 2020. Advances in Bioinformatics and Computational Biology. Advances in Bioinformatics and Computational Biology
93
104
.
Yulong Wang, Zhenfeng Li, Bogdan Barnych, Jingqian Huo, Debin Wan, Natalia Vasylieva, Junli Xu, Pan Li, Beibei Liu, Cunzheng Zhang & Bruce D. Hammock. (2019) Investigation of the Small Size of Nanobodies for a Sensitive Fluorescence Polarization Immunoassay for Small Molecules: 3-Phenoxybenzoic Acid, an Exposure Biomarker of Pyrethroid Insecticides as a Model. Journal of Agricultural and Food Chemistry 67:41, pages 11536-11541.
Crossref
Crossref
Lueacha Tabtimmai, Praphasri Suphakun, Pimonwan Srisook, Duangnapa Kiriwan, Siratcha Phanthong, Pichamon Kiatwuthinon, Wanpen Chaicumpa & Kiattawee Choowongkomon. (2019) Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival. Journal of Cellular Biochemistry 120:10, pages 18077-18087.
Crossref
Crossref
Barbara D. Jakobs, Lisa Spannagel, Vladimir Purvanov, Edith Uetz-von Allmen, Christoph Matti & Daniel F. Legler. (2019) Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7. International Journal of Molecular Sciences 20:10, pages 2597.
Crossref
Crossref
Alja Zottel, Alja Videtič Paska & Ivana Jovčevska. (2019) Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. Materials 12:10, pages 1588.
Crossref
Crossref
Melissa Togtema, Greg Hussack, Guillem Dayer, Megan R. Teghtmeyer, Shalini Raphael, Jamshid Tanha & Ingeborg Zehbe. (2019) Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. International Journal of Molecular Sciences 20:9, pages 2088.
Crossref
Crossref
Yushu Joy XieMichael DouganNoor JailkhaniJessica IngramTao FangLaura KummerNoor MominNovalia PisheshaSteffen RickeltRichard O. Hynes & Hidde Ploegh. (2019) Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice. Proceedings of the National Academy of Sciences 116:16, pages 7624-7631.
Crossref
Crossref
Roman V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Eugene D. Ponomarev & Irina V. Kholodenko. (2019) Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Current Medicinal Chemistry 26:3, pages 396-426.
Crossref
Crossref
Sameer Sachdeva, Hyun Joo, Jerry Tsai, Bhaskara Jasti & Xiaoling Li. (2019) A Rational Approach for Creating Peptides Mimicking Antibody Binding. Scientific Reports 9:1.
Crossref
Crossref
Wataru Aoki. 2019. Yeast Cell Surface Engineering. Yeast Cell Surface Engineering
123
147
.
Adel M. Zakri, Abdullah A. Al-Doss, Markus Sack, Ahmed A. Ali, Emad M. Samara, Basem S. Ahmed, Mahmoud. A. Amer, Omar. A. Abdalla & Mohammed A. Al-Saleh. (2018) Cloning and characterisation of nanobodies against the coat protein of Zucchini yellow mosaic virus. Plant Protection Science 54:4, pages 215-221.
Crossref
Crossref
Mostafa Modarresi, Mokhtar Jalali Javaran, Masoud Shams-bakhsh, Sirous Zeinali, Mahdi Behdani & Malihe Mirzaee. (2018) Transient expression of anti-VEFGR2 nanobody in Nicotiana tabacum and N. benthamiana. 3 Biotech 8:12.
Crossref
Crossref
Kerstin Schütze, Katharina Petry, Julia Hambach, Niklas Schuster, William Fumey, Levin Schriewer, Jana Röckendorf, Stephan Menzel, Birte Albrecht, Friedrich Haag, Catelijne Stortelers, Peter Bannas & Friedrich Koch-Nolte. (2018) CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells. Frontiers in Immunology 9.
Crossref
Crossref
Camilo E. Quevedo, Abimael Cruz-Migoni, Nicolas Bery, Ami Miller, Tomoyuki Tanaka, Donna Petch, Carole J. R. Bataille, Lydia Y. W. Lee, Phillip S. Fallon, Hanna Tulmin, Matthias T. Ehebauer, Narcis Fernandez-Fuentes, Angela J. Russell, Stephen B. Carr, Simon E. V. Phillips & Terence H. Rabbitts. (2018) Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nature Communications 9:1.
Crossref
Crossref
Mei Lu, Haonan Xing, Zhe Xun, Tianzhi Yang, Xiaoyun Zhao, Cuifang Cai, Dongkai Wang & Pingtian Ding. (2018) Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems. European Journal of Pharmaceutical Sciences 121, pages 34-46.
Crossref
Crossref
Abbas Shali, Sadegh Hasannia, Fatemeh Gashtasbi, Masoud Abdous, S. Shirin Shahangian & Shirin Jalili. (2018) Generation and screening of efficient neutralizing single domain antibodies (VHHs) against the critical functional domain of anthrax protective antigen (PA). International Journal of Biological Macromolecules 114, pages 1267-1278.
Crossref
Crossref
Urai Chaisri & Wanpen Chaicumpa. (2018) Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. BioMed Research International 2018, pages 1-23.
Crossref
Crossref
Kyle I. Mentkowski, Jonathan D. Snitzer, Sarah Rusnak & Jennifer K. Lang. (2018) Therapeutic Potential of Engineered Extracellular Vesicles. The AAPS Journal 20:3.
Crossref
Crossref
E. A. Vasilenko, V. V. Mokhonov, E. N. Gorshkova & I. V. Astrakhantseva. (2018) Bispecific Antibodies: Formats and Areas of Application. Molecular Biology 52:3, pages 323-334.
Crossref
Crossref
Dominik Schumacher, Jonas Helma, Anselm F. L. Schneider, Heinrich Leonhardt & Christian P. R. Hackenberger. (2018) Nanobodies: Chemical Functionalization Strategies and Intracellular Applications. Angewandte Chemie International Edition 57:9, pages 2314-2333.
Crossref
Crossref
Dominik Schumacher, Jonas Helma, Anselm F. L. Schneider, Heinrich Leonhardt & Christian P. R. Hackenberger. (2018) Nanobodys: Strategien zur chemischen Funktionalisierung und intrazelluläre Anwendungen. Angewandte Chemie 130:9, pages 2336-2357.
Crossref
Crossref
Anneleen Steels, Laurence Bertier & Jan Gettemans. 2018. Antibody Engineering. Antibody Engineering.
Thomas Eden, Stephan Menzel, Janusz Wesolowski, Philine Bergmann, Marion Nissen, Gudrun Dubberke, Fabienne Seyfried, Birte Albrecht, Friedrich Haag & Friedrich Koch-Nolte. (2018) A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation. Frontiers in Immunology 8.
Crossref
Crossref
Tiantian Wu, Hai Huang, Yaping Sheng, Hongdong Shi, Yuanzeng Min & Yangzhong Liu. (2018) Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery. Journal of Materials Chemistry B 6:7, pages 1011-1017.
Crossref
Crossref
Sander A. A. Kooijmans, Jerney J. J. M. Gitz-Francois, Raymond M. Schiffelers & Pieter Vader. (2018) Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. Nanoscale 10:5, pages 2413-2426.
Crossref
Crossref
Roghaye Arezumand, Abbas Alibakhshi, Javad Ranjbari, Ali Ramazani & Serge Muyldermans. (2017) Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers. Frontiers in Immunology 8.
Crossref
Crossref
Jalal Mosayebi, Mehdi Kiyasatfar & Sophie Laurent. (2017) Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications. Advanced Healthcare Materials 6:23, pages 1700306.
Crossref
Crossref
Peter Bannas, Julia Hambach & Friedrich Koch-Nolte. (2017) Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics. Frontiers in Immunology 8.
Crossref
Crossref
Yaozhong Hu, Changxiao Liu & Serge Muyldermans. (2017) Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy. Frontiers in Immunology 8.
Crossref
Crossref
Gualberto Gonzalez-Sapienza, Martín A. Rossotti & Sofía Tabares-da Rosa. (2017) Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications. Frontiers in Immunology 8.
Crossref
Crossref
Thomas Böldicke. (2017) Single domain antibodies for the knockdown of cytosolic and nuclear proteins. Protein Science 26:5, pages 925-945.
Crossref
Crossref
Shahryar Khoshtinat Nikkhoi, Fatemeh Rahbarizadeh & Davoud Ahmadvand. (2017) Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems. Protein Expression and Purification 129, pages 115-121.
Crossref
Crossref
Peter Schotte, Isabelle Dewerte, Manu De Groeve, Saskia De Keyser, Veronique De Brabandere & Patrick Stanssens. (2016) Pichia pastoris MutS strains are prone to misincorporation of O-methyl-l-homoserine at methionine residues when methanol is used as the sole carbon source. Microbial Cell Factories 15:1.
Crossref
Crossref
Hanke L. Matlung, Katka Szilagyi, Taco W. Kuijpers, Rene A.W. van Lier & Timo K. van den Berg. (2016) Immune checkpoint blockade: Which switches to hit and how much?. Immunology Letters 180, pages 73-74.
Crossref
Crossref
Xue Qiu, K. David Wegner, Yu-Tang Wu, Paul M. P. van Bergen en Henegouwen, Travis L. Jennings & Niko Hildebrandt. (2016) Nanobodies and Antibodies for Duplexed EGFR/HER2 Immunoassays Using Terbium-to-Quantum Dot FRET. Chemistry of Materials 28:22, pages 8256-8267.
Crossref
Crossref
Kyla R. Rodgers & Richard C. Chou. (2016) Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions. Biotechnology Advances 34:6, pages 1149-1158.
Crossref
Crossref
Jinny L. Liu, Dan Zabetakis, Ellen R. Goldman & George P. Anderson. (2016) Selection and characterization of single domain antibodies against human CD20. Molecular Immunology 78, pages 146-154.
Crossref
Crossref
Roghaye Arezumand, Reza Mahdian, Sirous Zeinali, Gholamreza Hassanzadeh-Ghassabeh, Kamran Mansouri, Hossein Khanahmad, Nabiollah Namvar-asl, Hamzeh Rahimi, Mahdi Behdani, Reza Ahangari Cohan, Mehdi Eavazalipour, Ali Ramazani & Serge Muyldermans. (2016) Identification and characterization of a novel nanobody against human placental growth factor to modulate angiogenesis. Molecular Immunology 78, pages 183-192.
Crossref
Crossref
Barbara Adamczyk, Simone Albrecht, Henning Stöckmann, Ibrahim M. Ghoneim, Marzook Al-Eknah, Khalid A. S. Al-Busadah, Niclas G. Karlsson, Stephen D. Carrington & Pauline M. Rudd. (2016)
Pregnancy-Associated Changes of IgG and Serum N-Glycosylation in Camel (
Camelus dromedarius
)
. Journal of Proteome Research 15:9, pages 3255-3265.
Crossref
Crossref
Maryam Qasemi, Mahdi Behdani, Mohammad Ali Shokrgozar, Vahid Molla-Kazemiha, Homa Mohseni-Kuchesfahani & Mahdi Habibi-Anbouhi. (2016) Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell. Protein Expression and Purification 123, pages 19-25.
Crossref
Crossref
Virginia J. Bruce, Monica Lopez-Islas & Brian R. McNaughton. (2016) Resurfaced cell-penetrating nanobodies: A potentially general scaffold for intracellularly targeted protein discovery. Protein Science 25:6, pages 1129-1137.
Crossref
Crossref
Shiva Ahdi Khosroshahi, Safar Farajnia, Mehdi Ghiamirad, Asghar Tanomand, Kamal Veisi, Leila Rahbarnia & Bahman Akbari. (2016) Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR). Protein Expression and Purification 120, pages 59-64.
Crossref
Crossref
S.A.A. Kooijmans, L.A.L. Fliervoet, R. van der Meel, M.H.A.M. Fens, H.F.G. Heijnen, P.M.P. van Bergen en Henegouwen, P. Vader & R.M. Schiffelers. (2016) PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. Journal of Controlled Release 224, pages 77-85.
Crossref
Crossref
Igor P. Dmitriev & Sergey A. Kaliberov. 2016. Adenoviral Vectors for Gene Therapy. Adenoviral Vectors for Gene Therapy
231
257
.
Amar BT Ghisaidoobe & Sang J Chung. (2015) Functionalized protein nanocages as a platform of targeted therapy and immunodetection. Nanomedicine 10:24, pages 3579-3595.
Crossref
Crossref
Gaowei Fan, Zujian Wang, Mingju Hao & Jinming Li. (2015) Bispecific antibodies and their applications. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
Di Wang, Shunli Yang, Shuanghui Yin, Youjun Shang, Ping Du, Jianhong Guo, Jijun He, Jianping Cai & Xiangtao Liu. (2015) Characterization of single-domain antibodies against Foot and Mouth Disease Virus (FMDV) serotype O from a camelid and imaging of FMDV in baby hamster kidney-21 cells with single-domain antibody-quantum dots probes. BMC Veterinary Research 11:1.
Crossref
Crossref
Muhammad Farooq Rai & Linda J. Sandell. (2015) Emerging Concepts in Gene Therapy for Osteoarthritis. Journal of the American Academy of Orthopaedic Surgeons 23:10, pages e56-e57.
Crossref
Crossref
Gustav Rodrigo, Mats Gruvegård & James Van Alstine. (2015) Antibody Fragments and Their Purification by Protein L Affinity Chromatography. Antibodies 4:3, pages 259-277.
Crossref
Crossref
Max A. Kruziki, Sumit Bhatnagar, Daniel R. Woldring, Vandon T. Duong & Benjamin J. Hackel. (2015) A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand Engineering. Chemistry & Biology 22:7, pages 946-956.
Crossref
Crossref
Martín Rossotti, Sofía Tabares, Lucía Alfaya, Carmen Leizagoyen, Gabriel Moron & Gualberto González-Sapienza. (2015) Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1850:7, pages 1397-1404.
Crossref
Crossref
Jakub Zbigniew Kaczmarek & Peter Durand Skottrup. (2015) Selection and characterization of camelid nanobodies towards urokinase-type plasminogen activator. Molecular Immunology 65:2, pages 384-390.
Crossref
Crossref
S. Shirin Shahangian, Reza H. Sajedi, Sadegh Hasannia, Shirin Jalili, Mohammad Mohammadi, Majid Taghdir, Abbas Shali, Kamran Mansouri & Reyhaneh Sariri. (2015) A conformation-based phage-display panning to screen neutralizing anti-VEGF VHHs with VEGFR2 mimicry behavior. International Journal of Biological Macromolecules 77, pages 222-234.
Crossref
Crossref
A. Naderi Sohi, M. Rajabibazl, M. J. Rasaee & K. Omidfar. (2015) The use of camel antibodies in development of EGFRvIII enzyme-linked immunosorbent assay. Applied Biochemistry and Microbiology 51:3, pages 374-380.
Crossref
Crossref
Elisabeth A van Erp, Lyudmila N Kaliberova, Sergey A Kaliberov & David T Curiel. (2015) Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein. Molecular Therapy - Oncolytics 2, pages 15001.
Crossref
Crossref
Peter C Fridy, Yinyin Li, Sarah Keegan, Mary K Thompson, Ilona Nudelman, Johannes F Scheid, Marlene Oeffinger, Michel C Nussenzweig, David Fenyö, Brian T Chait & Michael P Rout. (2014) A robust pipeline for rapid production of versatile nanobody repertoires. Nature Methods 11:12, pages 1253-1260.
Crossref
Crossref
Markus Fiedler & Arne Skerra. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
435
474
.
Sergey A Kaliberov, Lyudmila N Kaliberova, Maurizio Buggio, Jacqueline M Tremblay, Charles B Shoemaker & David T Curiel. (2014) Adenoviral targeting using genetically incorporated camelid single variable domains. Laboratory Investigation 94:8, pages 893-905.
Crossref
Crossref
Shunli Yang, Youjun Shang, Shuanghui Yin, Hong Tian, Yan Chen, Shiqi Sun, Ye Jin & Xiangtao Liu. (2014) Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus. Veterinary Immunology and Immunopathology 160:1-2, pages 12-19.
Crossref
Crossref
Anish Babu, Amanda K. Templeton, Anupama Munshi & Rajagopal Ramesh. (2014) Nanodrug Delivery Systems: A Promising Technology for Detection, Diagnosis, and Treatment of Cancer. AAPS PharmSciTech 15:3, pages 709-721.
Crossref
Crossref
Aneela Fatima, Haiying Wang, Keren Kang, Liliang Xia, Ying Wang, Wei Ye, Jufang Wang & Xiaoning Wang. (2014) Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis. PLoS ONE 9:4, pages e95263.
Crossref
Crossref
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, Hilde Revets, Nick Devoogdt, Tony Lahoutte, H. Kim Lyerly & Michael R. Zalutsky. (2014)
Improved Tumor Targeting of Anti-HER2 Nanobody Through
N
-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling
. Journal of Nuclear Medicine 55:4, pages 650-656.
Crossref
Crossref
M Lemaire, M D'Huyvetter, T Lahoutte, E Van Valckenborgh, E Menu, E De Bruyne, P Kronenberger, U Wernery, S Muyldermans, N Devoogdt & K Vanderkerken. (2013) Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies. Leukemia 28:2, pages 444-447.
Crossref
Crossref
Sabrina Oliveira, Raimond Heukers, Jirawas Sornkom, Robbert J. Kok & Paul M.P. van Bergen en Henegouwen. (2013) Targeting tumors with nanobodies for cancer imaging and therapy. Journal of Controlled Release 172:3, pages 607-617.
Crossref
Crossref
Tobias Schmidt Slørdahl, Tinneke Denayer, Siv Helen Moen, Therese Standal, Magne Børset, Cedric Ververken & Torstein Baade Rø. (2013)
Anti-c-MET Nanobody
®
- a new potential drug in multiple myeloma treatment
. European Journal of Haematology 91:5, pages 399-410.
Crossref
Crossref
Toya Nath Baral, Roger MacKenzie & Mehdi Arbabi Ghahroudi. (2013) Single‐Domain Antibodies and Their Utility. Current Protocols in Immunology 103:1.
Crossref
Crossref
Juan Diego Unciti-Broceta, Teresa Del Castillo, Miguel Soriano, Stefan Magez & Jose A Garcia-Salcedo. (2013) Novel therapy based on camelid nanobodies. Therapeutic Delivery 4:10, pages 1321-1336.
Crossref
Crossref
Isabel Van Audenhove, Katrien Van Impe, David Ruano-Gallego, Sarah De Clercq, Kevin De Muynck, Berlinda Vanloo, Hanne Verstraete, Luis Á. Fernández & Jan Gettemans. (2013) Mapping cytoskeletal protein function in cells by means of nanobodies. Cytoskeleton 70:10, pages 604-622.
Crossref
Crossref
Zahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad A. Shokrgozar, Davoud Ahmadvand, Fereidoun Mahboudi, Fatemeh Rahimi Jamnani & S. Moein Moghimi. (2013) Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents. Cancer Letters 334:2, pages 237-244.
Crossref
Crossref
Sai Pooja Mahajan, Camilo Velez-Vega & Fernando A. Escobedo. (2012) Tilting the Balance between Canonical and Noncanonical Conformations for the H1 Hypervariable Loop of a Llama VHH through Point Mutations. The Journal of Physical Chemistry B 117:1, pages 13-24.
Crossref
Crossref
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, Hilde Revets, Nick Devoogdt, Tony Lahoutte & Michael R. Zalutsky. (2013) Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody. Nuclear Medicine and Biology 40:1, pages 52-59.
Crossref
Crossref
C Goyvaerts, K De Groeve, J Dingemans, S Van Lint, L Robays, C Heirman, J Reiser, X-Y Zhang, K Thielemans, P De Baetselier, G Raes & K Breckpot. (2012) Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. Gene Therapy 19:12, pages 1133-1140.
Crossref
Crossref
Jingjing Zhu, Jeroen Declercq, Bart Roucourt, Gholamreza H. Ghassabeh, Sandra Meulemans, Jörg Kinne, Guido David, Alphons J. M. Vermorken, Wim J. M. Van de VenIris LindbergSerge Muyldermans & John W. M. Creemers. (2012) Generation and characterization of non-competitive furin-inhibiting nanobodies. Biochemical Journal 448:1, pages 73-82.
Crossref
Crossref
Kiavash Movahedi, Steve Schoonooghe, Damya Laoui, Isabelle Houbracken, Wim Waelput, Karine Breckpot, Luc Bouwens, Tony Lahoutte, Patrick De Baetselier, Geert Raes, Nick Devoogdt & Jo A. Van Ginderachter. (2012)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective
In Vivo
Imaging of Tumor-Associated Macrophages
. Cancer Research 72:16, pages 4165-4177.
Crossref
Crossref
Erwin De Genst & Christopher M. Dobson. 2012. Single Domain Antibodies. Single Domain Antibodies
533
558
.
Kien T. Maik & C. Roger MacKenzie. 2012. Single Domain Antibodies. Single Domain Antibodies
523
530
.
Toya Nath Baral & Mehdi Arbabi-Ghahroudi. 2012. Single Domain Antibodies. Single Domain Antibodies
257
275
.
André Schiefner, Lorenz Chatwell, Jana Körner, Irmgard Neumaier, David W. Colby, Rudolf Volkmer, K. Dane Wittrup & Arne Skerra. (2011) A Disulfide-Free Single-Domain VL Intrabody with Blocking Activity towards Huntingtin Reveals a Novel Mode of Epitope Recognition. Journal of Molecular Biology 414:3, pages 337-355.
Crossref
Crossref
Toya Nath Baral, Yanal Murad, Thanh-Dung Nguyen, Umar Iqbal & Jianbing Zhang. (2011) Isolation of functional single domain antibody by whole cell immunization: Implications for cancer treatment. Journal of Immunological Methods 371:1-2, pages 70-80.
Crossref
Crossref
Bieke Van de Broek, Nick Devoogdt, Antoine D’Hollander, Hannah-Laura Gijs, Karolien Jans, Liesbet Lagae, Serge Muyldermans, Guido Maes & Gustaaf Borghs. (2011) Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy. ACS Nano 5:6, pages 4319-4328.
Crossref
Crossref
Maryam SalavatifarShadi AminZahra Moghaddassi JahromiNasrin RasgooNasrin RastgooMehdi Arbabi. (2011) Green Fluorescent-Conjugated Anti-CEA Single Chain Antibody for the Detection of CEA-Positive Cancer Cells. Hybridoma 30:3, pages 229-238.
Crossref
Crossref
Huangxian Ju, Xueji Zhang & Joseph WangHuangxian Ju, Xueji Zhang & Joseph Wang. 2011. NanoBiosensing. NanoBiosensing
535
567
.
L. P. Daley-Bauer, S. R. Purdy, M. C. Smith, L. F. Gagliardo, W. C. Davis & J. A. Appleton. (2010) Contributions of Conventional and Heavy-Chain IgG to Immunity in Fetal, Neonatal, and Adult Alpacas. Clinical and Vaccine Immunology 17:12, pages 2007-2015.
Crossref
Crossref
Yi-Hui Audrey Teh & Tony A. Kavanagh. (2009) High-level expression of Camelid nanobodies in Nicotiana benthamiana. Transgenic Research 19:4, pages 575-586.
Crossref
Crossref
Diane E. Milenic. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer
1
38
.
Ilse Vaneycken, Jochen Govaert, Cécile Vincke, Vicky Caveliers, Tony Lahoutte, Patrick De Baetselier, Geert Raes, Axel Bossuyt, Serge Muyldermans & Nick Devoogdt. (2010) In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT. Journal of Nuclear Medicine 51:7, pages 1099-1106.
Crossref
Crossref
Joost A. Kolkman & Debbie A. Law. (2010) Nanobodies – from llamas to therapeutic proteins. Drug Discovery Today: Technologies 7:2, pages e139-e146.
Crossref
Crossref
Robert M. SharkeyEdmund A. RossiChien-Hsing ChangDavid M. Goldenberg. (2010) Improved Cancer Therapy and Molecular Imaging with Multivalent, Multispecific Antibodies. Cancer Biotherapy and Radiopharmaceuticals 25:1, pages 1-12.
Crossref
Crossref
Mehdi Arbabi-Ghahroudi, Roger MacKenzie & Jamshid Tanha. 2010. In Vitro Mutagenesis Protocols. In Vitro Mutagenesis Protocols
309
330
.
Sanne WA Reulen, Ingrid van Baal, Jos MH Raats & Maarten Merkx. (2009) Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester. BMC Biotechnology 9:1.
Crossref
Crossref
Peter Timmerman, Rodrigo Barderas, Johan Desmet, Danièle Altschuh, Susana Shochat, Martine J. Hollestelle, Jo W.M. Höppener, Alberto Monasterio, J.Ignacio Casal & Rob H. Meloen. (2009) A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity. Journal of Biological Chemistry 284:49, pages 34126-34134.
Crossref
Crossref
Carrie Enever, Thil Batuwangala, Chris Plummer & Armin Sepp. (2009) Next generation immunotherapeutics—honing the magic bullet. Current Opinion in Biotechnology 20:4, pages 405-411.
Crossref
Crossref
Jan Terje Andersen & Inger Sandlie. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy
293
310
.
Shenghua Li, Wenju Zheng, Rhonda KuoLee, Tomoko Hirama, Matthew Henry, Shokouh Makvandi-Nejad, Ted Fjällman, Wangxue Chen & Jianbing Zhang. (2009) Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response. Molecular Immunology 46:8-9, pages 1718-1726.
Crossref
Crossref
Seyed Hamid Aghaee BakhtiariFatemeh RahbarizadehSadegh HasanniaDavoud AhmadvandFarnoush Jafari Iri-SoflaMohammad Javad Rasaee. (2009) Anti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function. Hybridoma 28:2, pages 85-92.
Crossref
Crossref
Anita Y. Lam, Els Pardon, Konstantin V. Korotkov, Wim G.J. Hol & Jan Steyaert. (2009) Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus. Journal of Structural Biology 166:1, pages 8-15.
Crossref
Crossref
Jan Terje Andersen & Inger Sandlie. (2009) The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics. Drug Metabolism and Pharmacokinetics 24:4, pages 318-332.
Crossref
Crossref
Mehdi Arbabi-Ghahroudi, Roger MacKenzie & Jamshid Tanha. 2009. Therapeutic Antibodies. Therapeutic Antibodies
187
216
.
Kewal K. Jain. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
37
43
.
Davoud AhmadvandMohammad J. RasaeeFatemeh RahbarizadehMohammad Mohammadi. (2008) Production and Characterization of a High-Affinity Nanobody Against Human Endoglin. Hybridoma 27:5, pages 353-360.
Crossref
Crossref
Jan T. Andersen, Sune Justesen, Burkhard Fleckenstein, Terje E. Michaelsen, Gøril Berntzen, Vania E. Kenanova, Muluneh B. Daba, Vigdis Lauvrak, Søren Buus & Inger Sandlie. (2008) Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. The FEBS Journal 275:16, pages 4097-4110.
Crossref
Crossref
Davoud AhmadvandFatemeh RahbarizadehVahid Khoddami Vishteh. (2008) High-Expression of Monoclonal Nanobodies Used in the Preparation of HRP-Conjugated Second Antibody. Hybridoma 27:4, pages 269-276.
Crossref
Crossref
Ariane De Ganck, Veerle De Corte, An Staes, Kris Gevaert, Joël Vandekerckhove & Jan Gettemans. (2008) Multiple isoforms of the tumor suppressor myopodin are simultaneously transcribed in cancer cells. Biochemical and Biophysical Research Communications 370:2, pages 269-273.
Crossref
Crossref
Lieven Huang, Lea Olive Tchouate Gainkam, Vicky Caveliers, Chris Vanhove, Marleen Keyaerts, Patrick De Baetselier, Axel Bossuyt, Hilde Revets & Tony Lahoutte. (2008) SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression. Molecular Imaging and Biology 10:3, pages 167-175.
Crossref
Crossref
Michelle S. Bradbury, Hedvig Hricak & James R. Heath. 2008. Magnetic Resonance Tomography. Magnetic Resonance Tomography
1411
1433
.
Fredrik Y. Frejd. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
89
116
.
M. M. Harmsen & H. J. De Haard. (2007) Properties, production, and applications of camelid single-domain antibody fragments. Applied Microbiology and Biotechnology 77:1, pages 13-22.
Crossref
Crossref
Maneesh Jain, Neel Kamal & Surinder K. Batra. (2007) Engineering antibodies for clinical applications. Trends in Biotechnology 25:7, pages 307-316.
Crossref
Crossref
K Jain. 2007. Nanoparticulate Drug Delivery Systems. Nanoparticulate Drug Delivery Systems
173
183
.
Rob C. Roovers, Toon Laeremans, Lieven Huang, Severine De Taeye, Arie J. Verkleij, Hilde Revets, Hans J. de Haard & Paul M. P. van Bergen en Henegouwen. (2006) Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies. Cancer Immunology, Immunotherapy 56:3, pages 303-317.
Crossref
Crossref
M. Rajabi BazlM.J. RasaeeM. ForuzandehA. RahimpourJ. KianiF. RahbarizadehB. AlirezapourM. Mohammadi. (2007) Production of Chimeric Recombinant Single Domain Antibody—Green Fluorescent Fusion Protein in Chinese Hamster Ovary Cells. Hybridoma 26:1, pages 1-9.
Crossref
Crossref
Christian Kunz, Corina Borghouts, Claudia Buerger & Bernd Groner. (2006) Peptide Aptamers with Binding Specificity for the Intracellular Domain of the ErbB2 Receptor Interfere with AKT Signaling and Sensitize Breast Cancer Cells to Taxol. Molecular Cancer Research 4:12, pages 983-998.
Crossref
Crossref
Huguette Albrecht & Sally J. DeNardo. (2006)
Update
: Recombinant Antibodies: From the Laboratory to the Clinic
. Cancer Biotherapy and Radiopharmaceuticals 21:4, pages 285-304.
Crossref
Crossref
K.K. Jain. (2006) Nanoparticles as targeting ligands. Trends in Biotechnology 24:4, pages 143-145.
Crossref
Crossref
Imre Kacskovics, Balázs Mayer, Zsuzsanna Kis, László V. Frenyó, Yaofeng Zhao, Serge Muyldermans & Lennart Hammarström. (2006) Cloning and characterization of the dromedary (Camelus dromedarius) neonatal Fc receptor (drFcRn). Developmental & Comparative Immunology 30:12, pages 1203-1215.
Crossref
Crossref
Theresa Mikalsen, Nancy Gerits & Ugo Moens. 2006.
153
223
.
K. K. Jain. (2016) Role of Nanobiotechnology in Developing Personalized Medicine for Cancer. Technology in Cancer Research & Treatment 4:6, pages 645-650.
Crossref
Crossref
Mehdi Arbabi-Ghahroudi, Jamshid Tanha & Roger MacKenzie. (2005) Prokaryotic expression of antibodies. Cancer and Metastasis Reviews 24:4, pages 501-519.
Crossref
Crossref
Robert M Sharkey, Thomas M Cardillo, Edmund A Rossi, Chien-Hsing Chang, Habibe Karacay, William J McBride, Hans J Hansen, Ivan D Horak & David M Goldenberg. (2005) Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nature Medicine 11:11, pages 1250-1255.
Crossref
Crossref
An Ranquin, Wim Versées, Wolfgang Meier, Jan Steyaert & Patrick Van Gelder. (2005) Therapeutic Nanoreactors: Combining Chemistry and Biology in a Novel Triblock Copolymer Drug Delivery System. Nano Letters 5:11, pages 2220-2224.
Crossref
Crossref
Kewal K. Jain. (2005) The role of nanobiotechnology in drug discovery. Drug Discovery Today 10:21, pages 1435-1442.
Crossref
Crossref
M.H. Parker, Y. Chen, F. Danehy, K. Dufu, J. Ekstrom, E. Getmanova, J. Gokemeijer, L. Xu & D. Lipovsek. (2005) Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two. Protein Engineering, Design and Selection 18:9, pages 435-444.
Crossref
Crossref